The IVA-2 CPT is decision support software that helps clinicians test and evaluate both visual and auditory attention and response control functioning. It includes free online, self-scoring ADHD parent, teacher, and self-rating scales and a report writer that helps guide clinicians in making their diagnosis. By following a step-by-step process, you can evaluate the various factors needed to help you accurately diagnose ADHD in accordance with DSM-5 guidelines. Using the report writing system, you can complete an evaluation that includes your client’s clinical history, presenting symptoms, other psychological issues, clinical observations, rating scale results, and the IVA-2 test results. You can then make a diagnosis based on your comprehensive evaluation and can modify your report using the built-in, MS Word compatible word processor. It is now possible for you to administer, score the test, download the ADHD rating scale results, and complete your integrated and comprehensive report in less than an hour!
Validity research using the IVA CPT with children ages 7 to 12 had a sensitivity of 92% in identifying individuals diagnosed by a clinician as having ADHD. The IVA CPT also correctly identified the 90% of non-ADHD children (i.e., false positives = 10%). Another validity study for a typical mixed age clinical population (ages 6 to 55) found that as part of a clinician’s comprehensive psychological evaluation, the combination of the ADHD rating scale data with the IVA CPT matched the clinical diagnosis 90% of the time. In addition, this study did not misclassify 89% of individuals who did not have ADHD (i.e., 11% false positives). A summary review of the key IVA CPT research is available by clicking here.
“The IVA-2 has an incredible number of new features and ways of looking at the data. The report option will meet any needs you have and are wonderfully user-friendly. Report writing can be onerous and time consuming, but with IVA-2 it’s a dream. I liked the old IVA+Plus, but when the new IVA-2 came out – whooo!” – Anthea Stroman, R.N., Daniel Lowrance, Ph.D., Cales Psychology, Arlington, TX
Now you can have the freedom to administer the IVA-2 at an additional location without having to pay full-price for an additional station. For a one-time fee, you can add a special license to administer the IVA-2 from a second location. This license automatically renews at no additional charge when you renew your IVA-2 license. The new IVA-2 remote testing option allows you to administer tests from other locations online, on your iPad or even on your iPhone. Test data are uploaded back to your PC and are accessible only from your “master” IVA-2 license. Data are securely encrypted, and no PHI goes online.
Here’s how it works: from your IVA-2 license on your PC, you can generate codes to use IVA-2 test administrations you have purchased on your iPad or iPhone. You can then use the iPad or iPhone to administer those tests in a different location. The iPad or iPhone functions as a “clicker” so no external mouse is needed. You will, however, need headphones or external speakers. Once you have administered a test, the data will automatically upload back to your IVA-2 PC in the office.
If you prefer to administer your tests online, you can invest in an online remote testing license, which allows you to administer tests remotely from the Internet on any computer that supports the Chrome browser and Flash, including Macs or Surface Pros. As is the case with the iPad remote testing license, the data are automatically uploaded back to your IVA-2 PC once a test is completed. Test data are stored only on your actual IVA PC, not on the Internet or the remote testing device.
Note: Remote testing should only be administered under the clinical supervision of a qualified health care professional or technician. Remote test administration requires that the Examiner be able to validate that individuals completed the test in accordance with the specified test guidelines and performed to the best of their abilities. Testing can be administered either in-person or via interactive audio/video communication. The audio/video communication setup and functioning must enable the Examiner to view the individual being tested and their ongoing test responses during the entire test. For either in-person or remote testing It is the responsibility of the Examiner to determine if the test was administered in accordance with its guidelines and if an individual’s test compliance and effort was valid.
is decision support software that helps qualified healthcare professionals analyze and evaluate attention functioning.
includes free online parent, teacher and self ADHD rating scales.
provides a report writer that enables clinicians to create a customized diagnostic report based on their comprehensive evaluation.
is compatible for use with DSM-5®.
helps to assess possible malingering.
can easily be administered by a technician in only 15 minutes.
provides nine unique interpretive reports to help guide clinicians in better understanding their clients’ attention and response control problems.
utilizes ten different data analyses to provide in-depth information in both table and graph format to aid clinicians in interpreting the test scores and data.
How to use the IVA-2 Rating Scales – CLICK HERE
The IVA-2 Decision Support Software system provides the option to include up to nine FREE parent, teacher, and self ADHD rating scales that can be completed online. The rating scales are auto-scored, and summary data are confidentially downloaded to your computer. There is no identifying information ever available for any client online. To maintain confidentiality, the IVA-2 automatically generates unique random ID, passwords and identifiers for each individual. The IVA-2 is a great time-saver for you and helps you to better serve your clients’ needs. Note: You must administer a test to access the IVA ADHD rating scales. Click here to view samples of the questionnaire: Sample 1 Sample 2
DSM-5 is a trademark of the American Psychiatric Association.
The use of the IVA clinical decision software is restricted to licensed healthcare professionals with the appropriate training and experience in the administration and interpretation of this type of clinical software system. This system is not intended to be used as a standalone diagnostic instrument and by itself does not identify the presence or absence of any clinical diagnosis. The function of this decision support software is to aid providers in their analysis and interpretation of clinical data in as part of a comprehensive diagnostic evaluation. The system requires healthcare providers’ clinical input, validation and decision making in order to effectively use its suggestions and guidance in the creation of clinical reports for their clients.
The IVA-2 is a test of attention like all CPTs. The fact that the IVA-2 was found to significantly correlate with both QEEG and fMRI measures of attention provides validation that it truly measures what it was designed to measure (i.e., attentional functioning). Both QEEG and fMRI measures of attention have been found in various research studies to be useful in identifying individuals with ADHD and differentiating them with clinical efficacy.In light of the value of QEEG, the FDA approved a new QEEG based test last year after determining that it had sufficient clinical accuracy to be medically appropriate for use in helping clinicians in their diagnostic process when evaluating ADHD symptoms. This test was based in part of the research completed over 15 years ago by Dr. Joel Lubar and Dr. Vince Monastra, who identified the clinical sensitivity of QEEG analysis in classifying individuals with ADHD.
Thus, the IVA-2 test’s validity as a useful tool in the diagnostic process of clinicians is partly based on the fact that it is an accurate measure of the underlying psychophysiological processes of attention confirmed by independently completed research studies.
Why do Clinicians Need to Include the IVA-2 in ADHD Evaluations?
Research by Harrison, et al. (2007) concluded that the performance of college students who were instructed to simulate ADHD symptoms on standard ADHD rating scales was indistinguishable from those diagnosed as truly having ADHD; demonstrating that the symptoms of ADHD can be easily fabricated. Thus, clinicians cannot assume that students seeking either access to medications or academic accommodations will put forth their best effort and not exaggerate or magnify their symptom complaints. Identifying this type of “faking bad” behavior can be very challenging. However by including the IVA-2 in their comprehensive ADHD evaluations, clinicians can more accurately identify students who fake ADHD symptomatology. The IVA-2 provides clinicians with the option to evaluate possible malingering based on a published research study that demonstrated the effectiveness of the iVA-2 in identifying over 90% of college students who tried to simulate impaired test performance.